Description
FluQuadri 2025 Influenza Vaccine 0.5ml PFS - Pack of 5
This is a restricted schedule drug. Only to be sold to medical professionals. You will be required to provide your APHRA Registration Number/Scheduled Drug License.
An inactivated, split-virion quadrivalent flu vaccine to help protect against 2 influenza A and 2 influenza B strains each season. Registered for persons aged 6 months and older and supplied as five single-dose (0.5 mL) prefilled syringes for intramuscular injection.
Key features
-
Standard-dose QIV: 15 µg HA from each of the 4 WHO/AIVC-recommended strains (60 µg HA total per 0.5 mL dose). Egg-based, inactivated, split-virion.
-
Who it’s for: Approved for adults and children ≥6 months (follow the Australian Immunisation Handbook and local guidance).
-
Dose & schedule: 0.5 mL IM once each influenza season. Children who have not received influenza vaccine before may require 2 doses, 4 weeks apart—per official recommendations. NPS
-
Pack: Box of 5 single-dose prefilled syringes; needle may not be included depending on pack.
Composition & excipients
Each 0.5 mL dose contains 15 µg HA of each of the 4 strains. May contain traces of formaldehyde (≤100 µg), octoxinol-9 (≤250 µg), and ovalbumin (≤1 µg). No preservative; not made with natural rubber latex.
Storage & handling
-
Refrigerate at 2–8 °C. Do not freeze. Maintain cold chain; discard if frozen. NPS
Administration notes (for healthcare professionals)
-
IM only (deltoid for adults; anterolateral thigh for infants).
-
Do not mix with other vaccines in the same syringe. Inspect before use; do not use if discoloured or particulate matter is present. NPS
Regulatory information
-
ARTG ID: 213963
-
Sponsor: Sanofi-Aventis Australia Pty Ltd. Access Product Information and CMI via the TGA entry. Therapeutic Goods Administration (TGA)
Important: This information is intended for Australian healthcare professionals. Always consult the current Product Information and the Australian Immunisation Handbook when selecting and administering vaccines.
